Adjuvant Radiotherapy in Primary Mediastinal Lymphoma in Patients That Received R-CHOP
N/A
18 Years
65 Years
18 Years
65 Years
Not Enrolling
Both
Adjuvant Radiotherapy on Complete Remission Patients
Both
Adjuvant Radiotherapy on Complete Remission Patients
Trial Information
Adjuvant Radiotherapy in Primary Mediastinal Lymphoma in Patients That Received R-CHOP
Inclusion Criteria:
Diagnosis of primary mediastinal lymphoma No previous treatment performance status < 2
HIV, Hepatis B and C negative Normal :Renal, hepatic, pulmonary and cardiac function
Exclusion Criteria:
pregnancy
-
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
measurement of progression free-survival and overall survival at > 5 years
Outcome Description:
Assess if the use of adjuvant radiotherapy improve outcome in patients with primary mediastinal lymphoma treated initially with R-CHOP
Outcome Time Frame:
5 years
Safety Issue:
No
Authority:
Mèxico: National Research Counsil, Instituto Mexicano del Seguro Social
Study ID:
katty7
NCT ID:
NCT01230008
Start Date:
June 2002
Completion Date:
December 2009
Related Keywords:
- Adjuvant Radiotherapy on Complete Remission Patients
- primary mediastinal lymphoma
- radiotherapy
- chemotherapy
- rituximab
- Lymphoma
Name | Location |
|---|
